Compare OPTT & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OPTT | BGLC |
|---|---|---|
| Founded | 1984 | 2017 |
| Country | United States | Malaysia |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Medical Specialities |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.4M | 4.3M |
| IPO Year | 2006 | 2019 |
| Metric | OPTT | BGLC |
|---|---|---|
| Price | $0.16 | $1.48 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $1.50 | N/A |
| AVG Volume (30 Days) | ★ 3.9M | 9.4K |
| Earning Date | 03-17-2026 | 04-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 45.78 |
| EPS | ★ N/A | N/A |
| Revenue | $3,737,000.00 | ★ $7,424,911.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $221.57 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.13 | $1.07 |
| 52 Week High | $0.72 | $6.10 |
| Indicator | OPTT | BGLC |
|---|---|---|
| Relative Strength Index (RSI) | 37.62 | 42.89 |
| Support Level | $0.13 | $1.23 |
| Resistance Level | $0.45 | $1.88 |
| Average True Range (ATR) | 0.01 | 0.12 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 12.53 | 32.81 |
Ocean Power Technologies Inc provides intelligent maritime solutions and services that enable safer, cleaner, and more productive ocean operations for the defense and security, oil and gas, science and research, and offshore wind markets. It provides ocean data collection and reporting, marine power, offshore communications, and Maritime Domain Awareness System (MDAS) products, integrated solutions, and consulting services. The company offers its products and services to a wide range of customers, including those in government and offshore energy, oil and gas, construction, wind power, and other industries. The company has operations in North and South America, Europe, Asia and Australia.
BioNexus Gene Lab Corp is a Wyoming corporation with two principal operating subsidiaries in Malaysia: Chemrex Corporation Sdn. Bhd. (Chemrex) and MRNA Scientific Sdn. Bhd. (MRNA Scientific). Chemrex is engaged in the distribution of chemical raw materials, mainly for industrial applications in Southeast Asia. MRNA Scientific is engaged in the development and provision of blood-based genomic screening services intended to support early disease risk assessment and health management. Trading of industrial chemicals- Includes trading of industrial chemicals. Provision for genomic screening services- includes in commercializing proprietary blood-based diagnostic test for early disease detection. Investment holding- Investment holding, are its segments.